Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
0.9900
+0.0700 (7.61%)
At close: Apr 25, 2025, 4:00 PM
0.9801
-0.0099 (-1.00%)
After-hours: Apr 25, 2025, 4:23 PM EDT
BCLI Employees
Brainstorm Cell Therapeutics had 27 employees as of December 31, 2024. The number of employees decreased by 2 or -6.90% compared to the previous year.
Employees
27
Change (1Y)
-2
Growth (1Y)
-6.90%
Revenue / Employee
n/a
Profits / Employee
-$430,481
Market Cap
6.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BCLI News
- 18 days ago - BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn® in ALS - PRNewsWire
- 27 days ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 4 weeks ago - BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq - PRNewsWire
- 5 weeks ago - BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update - PRNewsWire
- 4 months ago - BrainStorm Issues 2024 Letter to Shareholders - PRNewsWire
- 5 months ago - BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update - PRNewsWire
- 5 months ago - BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology - PRNewsWire